Establishment Labs (NASDAQ:ESTA) Sets New 1-Year Low – Here’s Why

Establishment Labs Holdings Inc. (NASDAQ:ESTA)’s stock price hit a new 52-week low on Monday . The stock traded as low as $30.20 and last traded at $35.01, with a volume of 780735 shares traded. The stock had previously closed at $45.79.

Wall Street Analysts Forecast Growth

Several research analysts have recently issued reports on the stock. Stephens raised shares of Establishment Labs to a “strong-buy” rating in a research note on Monday, December 2nd. Citigroup raised their price objective on shares of Establishment Labs from $45.00 to $50.00 and gave the company a “neutral” rating in a research note on Tuesday, October 1st. Finally, BTIG Research upped their target price on shares of Establishment Labs from $62.00 to $65.00 and gave the company a “buy” rating in a research report on Monday, October 14th. One analyst has rated the stock with a hold rating, three have issued a buy rating and one has assigned a strong buy rating to the company. Based on data from MarketBeat.com, the company presently has an average rating of “Buy” and an average target price of $60.60.

Establishment Labs Stock Down 1.7 %

The firm has a market capitalization of $928.13 million, a price-to-earnings ratio of -12.85 and a beta of 1.15. The business’s 50-day moving average is $43.75 and its two-hundred day moving average is $43.60. The company has a debt-to-equity ratio of 5.94, a quick ratio of 2.29 and a current ratio of 3.62.

Institutional Investors Weigh In On Establishment Labs

Hedge funds have recently bought and sold shares of the company. Hood River Capital Management LLC bought a new stake in Establishment Labs during the 2nd quarter worth approximately $43,000. Point72 Asia Singapore Pte. Ltd. acquired a new position in shares of Establishment Labs in the third quarter valued at approximately $127,000. Nkcfo LLC bought a new stake in shares of Establishment Labs during the second quarter worth $227,000. Black Swift Group LLC acquired a new stake in shares of Establishment Labs during the third quarter worth $312,000. Finally, Verition Fund Management LLC lifted its position in Establishment Labs by 22.8% in the 3rd quarter. Verition Fund Management LLC now owns 9,400 shares of the company’s stock valued at $407,000 after acquiring an additional 1,746 shares in the last quarter. 72.91% of the stock is currently owned by institutional investors and hedge funds.

Establishment Labs Company Profile

Establishment Labs Holdings Inc, a medical technology company, manufactures and markets medical devices for aesthetic and reconstructive plastic surgery. The company primarily offers silicone gel-filled breast implants under the Motiva Implants brand. It also provides Motiva Ergonomix and Motiva Ergonomix2 gravity sensitive round soft silicone-gel-filled breast implants; and Motiva Flora Tissue Expander, a breast tissue expander.